The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Boston, MA

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Aditya Bardia is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Bardia is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Agranulocytosis, and Tissue Biopsy.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

Mehra Golshan is a General Surgeon practicing medicine in Boston, Massachusetts. Dr. Golshan is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Nadine Tung is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tung is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is board certified in American Board Of Internal Medicine.

Dr. Mayer received her medical degree from Harvard Medical School, completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at the Dana-Farber Cancer Institute. She also obtained a Masters in Public Health from the Harvard School of Public Health. She joined the staff of Dana-Farber and Brigham and Women's Hospital in 2006, where she serves as Director of Breast Cancer Clinical Research. She is a breast cancer medical oncologist and clinical investigator leading research studies focused on novel therapies for the treatment of breast cancer. Dr. Mayer is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Mayer is board certified in Medical Oncology.

Steven Isakoff is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Isakoff is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.

Paolo Tarantino is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tarantino is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. Dr. Tarantino is board certified in Npi 1619747359.

Leif Ellisen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Ellisen is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer.

Michaela Higgins is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Higgins is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Menopause, and Vitrectomy.

Beverly Moy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Moy is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Tissue Biopsy.

Ursula Matulonis is an Oncologist practicing medicine in South Weymouth, Massachusetts. Dr. Matulonis is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Tubal Ligation. Dr. Matulonis is board certified in Internal Medicine and Medical Oncology.

Laura Spring is an Oncologist practicing medicine in Danvers, Massachusetts. Dr. Spring is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Transplant. Dr. Spring is board certified in Medical Oncology.

Geoffrey Shapiro is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Shapiro is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy. Dr. Shapiro is board certified in Medical Oncology.

Dr. Suniti N. Nimbkar is a surgeon at Brigham and Women’s Hospital (BWH) , the medical director for the Breast Care Center at South Shore Hospital, in clinical affiliation with the Dana-Farber Brigham Cancer Center, and an instructor in surgery at Harvard Medical School.Dr. Nimbkar received her medical degree from Boston University School of Medicine and then completed a surgery residency at Boston University Medical Center (now Boston Medical Center). She is board certified in general surgery.Dr. Nimkar’s clinical and research interests include benign breast disease, breast conservation surgery, mastectomy with immediate reconstruction, nipple-sparing mastectomy, pregnancy-associated breast cancer and sentinel lymph node biopsy. Dr. Nimbkar is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Lymphadenectomy, and Mastectomy. Dr. Nimbkar is board certified in Surgery, General.

Dr. Metzger received his MD from Federal University of Minas Gerais in 2003 and completed training in Internal Medicine and Medical Oncology in 2008. Following his formal training, he spent three years at the Institute Jules Bordet in Brussels where he completed a research fellowship and initiated a career dedicated to understanding the biological features of the second most common histological subtype of breast cancer - invasive lobular carcinoma. Since joining the Breast Oncology Program at Dana-Farber Cancer Institute in 2012, he has established an active clinical practice and developed research efforts focused on identifying better treatment strategies for patients diagnosed with breast cancer. He is involved in designing and leading national and international clinical trials with a strong translational component. In addition to his physician and clinical investigator roles, Dr. Metzger holds an Executive Officer position at the Alliance for Clinical Trials in Oncology. Dr. Metzger is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and HER-2 Positive Breast Cancer.

Saritha Bolla is an Internal Medicine specialist and an Oncologist practicing medicine in Winchester, Massachusetts. Dr. Bolla is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer. Dr. Bolla is board certified in American Board Of Internal Medicine.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Waks is board certified in Internal Medicine and Medical Oncology.

Dr. Schlam received her medical degree from Anahuac University in Mexico City in 2014. She subsequently completed her Internal Medicine residency at The Jewish Hospital of Cincinnati and then her Hematology and Medical Oncology fellowship at The MedStar Georgetown Washington Hospital Center in Washington, DC. She obtained her Masters in Public Health from the Harvard School of Public Health in 2024. She was faculty at Tufts Medical Center from 2021 to 2024. In 2024, she joined the staff of the Dana-Farber Cancer Institute as a breast medical oncologist and clinical researcher. Her research focuses on drug development, identifying markers of response to novel therapies and healthcare disparities. Dr. Camhi is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Camhi is board certified in Internal Medicine, Hematology, and Medical Oncology.